---All---
  • ---All---
  • Accession
  • Catalog #

CDKN1B AntibodyMouse Monoclonal Antibody to CDKN1B

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AO1379a 0.1ml 400 ul 7-10 days $ 325.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

CDKN1B Antibody - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP46527
Other AccessionNP_004055.1
ReactivityHuman
IsotypeMouse IgG1
Clone Names3D8
Calculated MW22073 Da

CDKN1B Antibody - Additional info

Gene ID 1027
Other Names
KIP1; MEN4; CDKN4; MEN1B; P27KIP1; CDKN1B
Target/Specificity
Purified recombinant fragment of human CDKN1B expressed in E. Coli.
Dilution
WB~~1:500 - 2000.
Format
Purified recombinant fragment of human CDKN1B expressed in E. Coli.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
CDKN1B Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

CDKN1B Antibody - Protein Information

Name CDKN1B
Synonyms KIP1
Function
Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1- CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry
Cellular Location
Nucleus. Cytoplasm. Endosome (By similarity). Note=Nuclear and cytoplasmic in quiescent cells. AKT- or RSK-mediated phosphorylation on Thr-198, binds 14-3-3, translocates to the cytoplasm and promotes cell cycle progression Mitogen-activated UHMK1 phosphorylation on Ser-10 also results in translocation to the cytoplasm and cell cycle progression Phosphorylation on Ser-10 facilitates nuclear export. Translocates to the nucleus on phosphorylation of Tyr-88 and Tyr-89 Colocalizes at the endosome with SNX6; this leads to lysosomal degradation (By similarity)
Tissue Location
Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney

CDKN1B Antibody - Related products

AP10418a: 27Kip1-T157 Antibody

AP13302b: CDKN1B Antibody (C-term)

AP3191a: Phospho-p27Kip1-S10 Antibody

AP3192a: Phospho-p27Kip1-S178 Antibody

AP3193a: Phospho-p27Kip1-T157 Antibody

AP3194a: Phospho-p27Kip1-T187 Antibody

AP3529a: Phospho-p27Kip1-T198 Antibody

AP6269b: 27Kip1 Antibody (C-term)

RI10983: CDKN1B predesign siRNA

LY12364a: CDKN1B Over-expression Lysate

BP10418a: 27Kip1-T157 Antibody Blocking peptide

BP3191a: Phospho-p27Kip1-S10 Antibody Blocking Peptide

BP3192a: Phospho-p27Kip1-S178 Antibody Blocking Peptide

BP3193a: Phospho-p27Kip1-T157 Antibody Blocking Peptide

BP3194a: Phospho-p27Kip1-T187 Antibody Blocking Peptide

BP3529a: Phospho-p27Kip1-T198 Antibody Blocking Peptide

BP6269b: 27Kip1 Antibody (C-term) Blocking Peptide

AT1481a: CDKN1B Antibody (monoclonal) (M01)

AO1379a: CDKN1B Antibody

AJ1569c: p27/Kip1 Antibody (C-term)

AJ1569d: p27/Kip1 Antibody Phospho (pS10)

AF1591a: KIP1 / CDKN1B (internal) Antibody

AF1769a: P27KIP1 / CDKN1B (C Terminus) Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

p27 KIP 1 is a cell cycle regulatory mitotic inhibitor of cdk activity. p27 KIP 1 is a candidate tumor suppressor gene, and has been proposed to function as a possible mediator of TGF beta induced G1 arrest. p27 KIP 1 is up regulated in response to antimitogenic stimuli. The increased protein expression of p27 results in cellular arrest by binding to cyclin/Cdk complexes such as cyclin D1/Cdk4. Decreased levels of p27Kip1, mainly due to proteosomal degradation, are found in various epithelial tumors originating from lung, breast, colon, ovary, esophagus, thyroid and prostate.Tissue specificity: Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney.

REFERENCES

1. Exp Mol Med. 2009 Nov 30;41(11):765-71.
2. Int J Gynecol Pathol. 2010 Jan;29(1):8-18.